ABSTRACT Insulin concentrations in acid/ethanol extracts of the whole rat brain were on the average 25 times higher than plasma insulin levels. Brain insulin was indistinguishable from authentic pancreatic insulin, based on its behavior in radioimmunoassay, radioreceptor assay, and bioassay and its chromatographic pattern on Sephadex G-50 column chromatography. Insulin was found in all regions of the brain examined, but distribution was uneven. Some regions had insulin concentrations as much as 100 times higher than in plasma; levels at least 10 times higher were found in other regions. Recently, we have found that insulin receptors are widely distributed in the central nervous system of the rat (9). Therefore, we were interested to see if insulin itself was present in the central nervous system. In the present study, we have found that insulin concentrations in brain far exceeded insulin levels in blood. Insulin concentrations in extracts of whole brain were, on the average, 25 times higher than in plasma. Different discrete regions of the central nervous system varied in their insulin content, and concentrations between 10 and 100 times higher than plasma were observed. Insulin in brain tissue was determined by a radioimmunoassay and further characterized by radioreceptor assay, bioassay, and chromatography. Concordance of all these methods demonstrated that genuine insulin or an extremely similar peptide was present in the central nervous system. MATERIALS AND METHODS Extraction Procedure. A standard type of extraction procedure was used (10). Male Sprague-Dawley rats (250-300 g) fed ab lib were killed by decapitation at 1600; the brain (including the pituitary) was removed and kept on ice during the whole dissection procedure. Whole brain and macroscopically dissected discrete regions were homogenized (Polytron) in 10 vol of ice-cold 0.2 M HCI/75% ethanol (acid-ethanol).
ABSTRACT Insulin concentrations in acid/ethanol extracts of the whole rat brain were on the average 25 times higher than plasma insulin levels. Brain insulin was indistinguishable from authentic pancreatic insulin, based on its behavior in radioimmunoassay, radioreceptor assay, and bioassay and its chromatographic pattern on Sephadex G-50 column chromatography. Insulin was found in all regions of the brain examined, but distribution was uneven. Some regions had insulin concentrations as much as 100 times higher than in plasma; levels at least 10 times higher were found in other regions. The role of insulin in the central nervous system is not clear at present but, because both insulin and insulin receptors are abundant in the central nervous system, an extensive physiological regulation of the central nervous system by insu in is proposed. The central nervous system is not generally considered to be an insulin-dependent tissue. The search for classical effects of insulin on nervous tissue either in vivo or in vitro has yielded conflicting results. Effects of insulin unrelated to glucose metabolism have not been widely investigated, possibly because the blood/brain barrier was thought to be impermeable to insulin. During the last 10 years, evidence has been presented that insulin can, in fact, cross the blood/brain barrier (1, 2) and, under certain circumstances, act on the central nervous system (3) (4) (5) (6) (7) (8) .
Recently, we have found that insulin receptors are widely distributed in the central nervous system of the rat (9) . Therefore, we were interested to see if insulin itself was present in the central nervous system. In the present study, we have found that insulin concentrations in brain far exceeded insulin levels in blood. Insulin concentrations in extracts of whole brain were, on the average, 25 times higher than in plasma. Different discrete regions of the central nervous system varied in their insulin content, and concentrations between 10 and 100 times higher than plasma were observed. Insulin in brain tissue was determined by a radioimmunoassay and further characterized by radioreceptor assay, bioassay, and chromatography. Concordance of all these methods demonstrated that genuine insulin or an extremely similar peptide was present in the central nervous system.
MATERIALS AND METHODS
Extraction Procedure. A standard type of extraction procedure was used (10) . Male Sprague-Dawley rats (250-300 g) fed ab lib were killed by decapitation at 1600; the brain (including the pituitary) was removed and kept on ice during the whole dissection procedure. Whole brain and macroscopically dissected discrete regions were homogenized (Polytron) in 10 vol of ice-cold 0.2 M HCI/75% ethanol (acid-ethanol).
The suspension was stirred or shaken overnight at 40C. After centrifugation at 3500 rpm for 20 min at 40C, the supernatants
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. Gel Filtration. Lyophilized extracts were dissolved in 0.05 M (NH4)2CO3 containing bovine serum albumin (1 mg/ml), applied to a Sephadex G-50 (fine) column (1.5 X 90 cm), and eluted with the same solution (11) . The column was calibrated with 125I-labeled thyroglobulin, 125I-insulin, and NaI25I. Insulin concentrations in the effluent fractions were determined by radioimmunoassay. Based on the results of radioimmunoassay, selected fractions were pooled, lyophilized, and reconstituted for radioreceptor assay or bioassay or both.
Radioreceptor Assay. Filtrates from the Sephadex G-50 column were lyophilized and reconstituted in a Hepes buffer for study in the radioreceptor assay, using insulin receptors on IM-9 lymphocytes, porcine 125I-insulin, and porcine insulin as a standard (12) . Degradation of 125I-insulin was measured as a loss of precipitability in 5% trichloroacetic acid; the degradation was 7% or less of the total radioactivity.
Bioassay Procedure. The biological activity in effluent fractions from the Sephadex G-50 column was determined by measuring the conversion of [U-14C]glucose to 14CO2 by isolated fat cells prepared from epididymal fat pads of young rats (13) . Porcine insulin was used as a standard. Guinea pig antiporcine insulin antibody at a final dilution of 1:100 was used to neutralize the bioactivity of the standard and selected samples.
Immunocytochemical Localization of Insulin. SpragueDawley rats (2 weeks old) were anesthetized with ether and perfused through the aorta with a modified Zamboni fixative (14) . The brain was dissected, postfixed for 4-6 hr, and washed overnight in Tris-buffered saline (Tris/NaCl). Sections were cut on a Vibratome at a thickness of 20 gm and exposed to 0.25% Triton X-100 in Tris/NaCl for 15 min, washed three times with Tris/NaCl, and then blocked with 10% normal sheep serum/0. 1 M lysine in Tris/NaCl for 1 hr. Sections were then incubated with either guinea pig anti-bovine insulin at 1:20 dilution or control guinea pig serum at the same dilution for 1 hr at room temperature and washed; protein A-peroxidase (15) was applied for 30 min. After further washing, the sections were treated with 0.05% diaminobenzidine/0.01% H202 for 5-8 min.
The stained sections were mounted on slides, coverslipped, and photographed on a Leitz microscope equipped with interference contrast optics. Control sections showed no background, and anti-insulin antiserum with free insulin present resulted in decreased staining.
RESULTS
Nine separate extractions of the whole rat brain, including the pituitary, are summarized in Table 1 . The average insulin content, as determined by the radioimmunoassay and corrected for losses during extraction, was 23 ng/g of wet brain, so that the average insulin concentration was 26 times higher than mean plasma insulin (0.9 ng/ml). In one experiment (E), low levels were found; in another one (C), very high levels were found. We do not know what accounts for the variability of the results; possibly the animals may have varied in their food intake. The recovery of 125I-insulin was similar on different days and ranged between 31 and 44%. Also, the pancreatic insulin levels, determined twice in parallel, were similar to previously published results. In any case, because the plasma insulin levels ranged between 0.5 and 1.2 ng/ml, the central nervous system insulin concentrations were at the least 2 times, and at most 200 times, higher than plasma insulin concentrations.
In the radioimmunoassay (Fig. 1) , the extracts of whole brain and of the hypothalamus were compared to the pork insulin and rat insulin standards over a 10-fold range of dilutions and gave a curve situated between the rat and pork standards. The reason for the difference between the standard and the extract is not entirely clear. Because our rat standard was a few years old, it may be that some loss of activity had occurred. Alternatively, it may be that cerebral insulin is not exactly immunologically identical to pancreatic insulin.
The insulin immunoreactivity in the extract of the whole rat brain was eluted from the Sephadex G-50 column in a position close to that of the labeled pork insulin standard (Fig. 2) . No distinct peak was detected in the proinsulin region, but the total amount of insulin on the column was small and our antibody reacts less well with proinsulin than with insulin. Thus, proinsulin would not have been detected unless it constituted more than 20% of the total immunoactive material.
Effluent fractions that contained the immunoassayable insulin were pooled, lyophilized, reconstituted in buffer, and tested in a radioreceptor assay. Over a 10-fold range of dilution, the material tested was similar to pork insulin in competing with 125I-insulin for binding to insulin receptors on IM-9 lymphocytes (Fig. 3) . The insulin receptor on these cells is identical to insulin receptors on classical target tissues such as liver and fat. The actual amount of insulin detected in the radioreceptor assay (about 60 ng/ml) was similar to that determined by the radioimmunoassay (100 ng/ml).
Finally, the biological activity of the gel-filtered brain extract was measured in the glucose oxidation assay (Fig. 4) . 14CO2
produced by increasing concentrations of insulin standard was similar to that produced by increasing volumes of extract. The amount of insulin predicted by the bioassay (about 7 ng/ml) was confirmed in the radioimmunoassay (7.9 ng/ml). An excess of anti-insulin antibody fully neutralized the bioactivity of the brain extract and the insulin standard as shown by the decrease of glucose oxidation to basal levels. olfactory bulb and cerebellum. Lower values, but still 10-20 times higher than plasma levels, were found in the brainstem, cerebral cortex, and remaining brain tissue. There was no apparent correlation between the receptor content and insulin content; for example, the cerebral cortex and the hypothalamus have similar levels of insulin binding sites, but the insulin concentration was low in the cortex and high in the hypothalamus.
In preliminary attempts to localize the insulin in the central nervous system by means of immunocytochemistry, we have found neuronal perikarya in the olfactory bulb and frontal cortex of the immature rat that appear to contain this hormone. The staining was markedly decreased when preimmune serum was used instead of serum containing anti-insulin antibodies. Furthermore, staining was blocked by preincubating the anti-insulin serum with insulin prior to its application to the tissue sections (Fig. 6) . DISCUSSION Our data show that the concentration of insulin in the central nervous system is considerably higher than its concentration in plasma. In the whole brain extract, average concentrations' about 25 times higher than plasma were observed. The level of insulin was at least 10 times higher than that found in plasma in every area studied, and in some regions concentrations 100 times higher than in plasma were measured. Because the brain extract behaved similarly to insulin standard in the radioimmunoassay, radioreceptor assay, and bioassay, it is likely that genuine insulin or a very similar peptide is present. If one of the insulin-like growth factors or a proinsulin-like peptide were present, such close correlation between the assays would not have been obtained. Also, the chromatography results are suggestive of a peptide very close, if not identical, to insulin.
What is the origin of the brain insulin? Because insulin levels in the brain exceed plasma levels, it is unlikely that our results can be explained by contamination of the brain by circulating insulin. It is even less likely that the cerebrospinal fluid insulin is responsible for results obtained because the concentration of insulin in the cerebrospinal fluid is only about 25% of the plasma level (1) and its volume, relative to the brain volume, is very small.
It is possible that pancreatic insulin present in the plasma and cerebrospinal fluid is taken up and stored by cells in the brain. The blood/brain barrier has been found to be slowly and in- In view of evidence from our own (18) and other laboratories (19) that insulin receptors are present on synaptosomes, it is possible that insulin plays a role in neurotransmission, either as a neurotransmitter itself or as a neuromodulator. It has been known for some time that exogenously administered insulin (into the carotid artery, the cerebrospinal fluid, or the brain parenchyma) can induce some effect within the central nervous system that eventually results in neurally mediated peripheral hypoglycemia (3) (4) (5) (6) (7) (8) . It may be that this effect is produced by insulin acting through receptors on specific central cells. The list of peptides identified in both the central nervous system and the gastrointestinal tract is rapidly expanding (20) (21) (22) (23) (24) (25) (26) (27) . Some of these gastrointestinal peptides, such as somatostatin, vasoactive intestinal polypeptide, and thyrotropin-releasing hormone, are included among the putative neuroregulators (28) .
Because insulin and insulin receptors are ubiquitous throughout the central nervous system (9), we anticipate an extensive physiological role for insulin in this system, although we were not able at this time to define it. In preliminary studies, we have found that genetically obese (ob/ob) diabetic mice, in which circulating insulin is markedly increased and insulin receptors in liver, fat, and other tissues are severely decreased, have normal concentrations of insulin and of insulin receptors in the brain. In related studies, in rats rendered hypoinsulinemic and diabetic by treatment with streptozotocin there was no decrease in the concentration of brain insulin. These preliminary data, in addition to strengthening the possibility that brain insulin is produced locally, suggest that insulin and insulin receptors in the central nervous system are regulated independently of their counterparts outside the nervous system.
